Kinaxis: Accelerating Life-Changing Treatments with Sobi

Leading biopharmaceutical company Sobi has selected end-to-end supply chain orchestration provider Kinaxis to enhance its supply chain visibility and efficiency.

Sobi is set to enjoy better access to scenario planning, data management and precision through Kinaxis' platform.

The AI implementation will help deliver critical therapies to new patients at a faster speed. 

Maestro meets medicare

Sobi (Swedish Orphan Biovitrum AB) is a global biopharmaceutical company working to manufacture innovations that help those living with rare diseases.

It aims to take hold of scientific opportunities, grasping other technologies and discoveries to ensure it is using everything it can to unlock a breakthrough in critical therapies.

Currently, only 5% of rare diseases have approved medicines, which means the need for new developments is incredibly high. 

Sobi is constantly expanding new treatments and products, focusing on widening global access to these treatments. It has more than 40,000 patients every year across 55 countries, all of which are relying on supply chain efficiency to receive these much-needed treatments.

It is focused on hematology, immunology and specialty care, with its operations headquartered in Stockholm, Sweden. 

Now, it is implementing the Kinaxis Maestro platform to create end-to-end collaboration across partner networks and create more efficient decision-making.

Maestro, an AI-powered orchestration platform enabling end-to-end supply chain transformation, allows business to unlock supply chain opportunities with speed and precision. 

By implementing Maestro, Sobi can pursue faster treatment R&D, as well as faster delivery. As a result, patients can receive much-need treatment with higher levels of efficiency. 

“Sobi’s work changes lives and we’re proud to support them in delivering on that mission,” says Fabienne Cetre, Executive Vice President for EMEA at Kinaxis.

“Sobi will utilise Maestro to unlock real-time collaboration and seamless execution in order to fast-track the delivery of critical therapies worldwide.”

Increasing efficiency with Maestro

Maestro helps businesses make smart decisions at a total lower cost as can be implemented across entire supply chains. 

It creates a single source of accurate information by connecting and contextualising internal and external data sources, using real-time insights and adaptive solutions in a more efficient manner than both human entry and other digital platforms.

Moreover, Maestro is build with intuitive user interface, meaning collaboration is seamless. Maestro automatically and instantly captures new changes across the ecosystem, meaning that Sobi is be made aware of any new advancements which might aid its mission. 

It allows for the future-proofing of supply chains by running scenarios and creating countless supply chain digital twins. Sobi will be able to run scenarios and trial new information without risk of wasting resources or hurting people. It represents a safe way to trial new innovations in a virtual space.

Maestro also tracks historical context to help with decision-making on KPIs, meaning it is aware of every trial Sobi has already undertaken and can help avoid failed repetitions. 

Due to Maestro's flexible architecture, it can track new emerging technologies and ensure Sobi's supply chain stays at the forefront of innovation. 

“Kinaxis is well-regarded in the life sciences sector for its understanding of the unique complexities of supply chains that define this specific industry,” adds Norbert Schoellhorn, VP Global Manufacturing and Supply Chain at Sobi.

“Sobi will utilise Maestro to unlock real-time collaboration and seamless execution in order to fast-track the delivery of critical therapies worldwide.”

An established partner

Kinaxis has long been established as a leading supply chain technology partner for the life sciences industry, including Merck, Novartis, Cardinal Health, Boston Scientific and more. 

As its newest partner, Sobi is sure to witness almost immediate supply chain transformation.

With its supply chain management solutions, Kinaxis Maestro allows teams to focus on the important parts of biopharmaceutical manufacturing, taking care of routine tasks and predictive algorithms.

Maestro's advanced data management means teams can achieve superior performance, which, for Sobi, translates as faster delivery of critical therapies.